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This study covers a modified semi-quantitative approach for liquid chromatography mass 
spectrometry (LC-MS/MS) signature peptide detection for body fluid identification. Peptide 
concentrations were measured based on synthetic peptide standards. Samples were processed 
with varying trypsin digestion and purification protocols, including a three-hour trypsin digestion 
and Microcon membrane filtration. The Microcon filtration method generates polymerase chain 
reaction (PCR) compatible DNA and peptide fractions that can be analyzed without any further 
purification. Preliminary validation tests covered stains on different substrates, semen/ saliva 
mixtures, minimum sample volume, and repeatability. All signature peptides in the multiplex 
were present at different concentrations and varied amongst donors. Saliva peptides were 
detected at lower concentrations and had a higher minimum sample volume. Semen peptides 
could be detected even as a minor component in a mixture. All semen and saliva peptides were 








The identification of biological fluids at a crime scene can aide to determine the suspect 
or victim, exonerate an innocent person, provide clues for reconstruction by connecting the 
sample donor to the scene of the criminal act, corroborate witness testimony of the sequence of 
events, and assist further investigation (Yang, Zhou, Deng, Prinz & Siegel, 2013; An, Shin, 
Yang, & Lee, 2012; Virkler & Lednev, 2009). Furthermore, blood stains can be an indicator of a 
physical assault, struggle, or murder, while semen and/or vaginal fluid can provide leads to a 
sexual act or assault (Virkler & Lednev, 2009). Blood, semen, saliva, vaginal fluid, urine, and 
sweat are the body fluids that are common in forensic casework (Yang et al., 2013; An et al., 
2012; Virkler & Lednev, 2009). Having identified a body fluid routinely leads to further 
laboratory testing, such as DNA analysis, which can be the source of highly probative 
information.  
Body fluid identification can be a difficult task because some biological stains are similar 
in appearance to other stains or not visible to the naked eye; hence, an absolute and objective 
confirmation is mandated (Virkler & Lednev, 2009). This fact becomes critical when there is a 
possible occurrence of mixed stains (Virkler & Lednev, 2009). A stain can contain various 
biological fluids from multiple donors. In these cases, it is important to identify all possible body 
fluids and link all possible donors. The project presented here focused on an alternative method 
for detecting semen and saliva, two body fluids of interest in sexual assaults; background on both 






 Human saliva is a clear and slightly acidic substance that secretes from exocrine glands 
(Humphrey & Williamson, 2001). It is a complex mixture of fluids released from the major and 
minor salivary glands and the mucosal gingival crevicular fluids that contain oral bacteria and 
food debris (Humphrey & Williamson, 2001; Proctor, 2016). The major salivary glands include 
the parotid glands, the submandibular and sublingual glands (Humphrey & Williamson, 2001). 
Minor glands that secrete saliva are located in the lower lip, palate, tongue, cheeks, and pharynx 
(Humphrey & Williamson, 2001). Saliva is largely composed of amylase, lysozyme and mucin 
(Virkler & Lednev, 2008; Zapata, Fernández de La Ossa & García-Ruiz, 2015).  
Semen Physiology 
Human semen is a complex mixture of fluids secreted from several glands. These fluids 
are partially fused during ejaculation, creating an initially non-homogenous mixture (Owen & 
Katz, 2005). The first portion of the ejaculate is secreted from the bulbourethral and periurethral 
glands (Owen & Katz, 2005). The second portion is secreted from the prostate, and the majority 
of the ejaculate comes from seminal vesicles (Owen & Katz, 2005). The majority of seminal 
fluid is secreted from the seminal vesicles and this solution is composed of alkaline, fructose, 
citrate, and prostaglandins (Owen & Katz, 2005; Revenig, Leung, & Hsiao, 2014). More 
information on the composition of seminal fluid is given in Table 1.  
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Seminal vesicles 65-75 Alkaline, fructose, citrate, prostaglandins 
Prostate 15-30 Acid phosphatase, citric acid, serine proteases, zinc 
Vas deferens 5-10 Spermatozoa 
Bulbourethral and 
periurethral glands 
1-5 Pre-ejaculate, galactose, mucous 
 
Traditional Body Fluid Identification Techniques and Limitations 
Body fluid tests are classified into two groups: 1) presumptive and 2) confirmatory. 
Presumptive tests are utilized to provide an indication of the identity of the fluid. Presumptive 
testing may result in false positives and are not specific to a single body fluid; therefore, a 
confirmatory test must be conducted to validate the identity of the body fluid in the stain (Zapata  
et al., 2015; Yang et al., 2013; An et al., 2012; Vincini, 2010; Virkler & Lednev, 2009). Unlike 
presumptive tests, confirmatory tests are specific and a positive result for a particular body fluid 
indicates the presence of that fluid.  
Methods employed for body fluid identification include spectroscopy, microscopy, 
chemical tests, immunological tests, and protein catalytic activity tests (Zapata et al., 2015). 
Some of these methods are presumptive, while others are confirmatory. Generally, chemical or 
enzymatic techniques are presumptive, while microscopic or immunological techniques are 
confirmatory (Harbison & Fleming, 2016). Catalytic, enzymatic, and immunological methods 
have low specificity, are destructive, not sensitive, and may interfere with other tests (Yang et 





Alternate Light Source 
The use of an alternate light source (ALS) is a straightforward, noninvasive, and 
nondestructive spectroscopic technique that’s often used to analyze body fluids, fingerprints, and 
other trace evidence (Miranda, Prado, Delwing, & Daruge, 2014). It is routine to analyze an area 
using ALS before the application of any reagent (Miranda et al., 2014). ALS takes advantage of 
the light absorptive or photoluminescent properties of some substances when they are examined 
at a particular wavelength (Viner, Kagan, & Johnson, 2014). For semen, the excitation spectrum 
is broad ranging from 300 to 480 nm (Vandenberg & Van Oorschot, 2006). Nonetheless, semen 
was observed to undergo optimal visualization at an excitation wavelength of 455 nm, depending 
on the substrate (Sheppard, Cassella, Fieldhouse, & King, 2017). It was observed that saliva can 
be optimally visualized at 470 nm, on a cotton substrate (Tay et al., 2020). A summary of the 
light source devices that have been employed for semen and saliva identification can be found in 
Table 2. False positive results may occur with bacitracin zinc, barrier cream, hand cream, castile 
soap, Surgilube® lubricant, toothpaste and A&D ointment (Zapata et al., 2015).  
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Table 2: Various ALS techniques utilized to detect semen and saliva. 







Wood’s Lamp 320-400  Yes No (Nelson & Santucci, 2002; An et al., 2015; 





Yes No (Nelson & Santucci, 2002; An et al., 2015; 
Virkler & Lednev, 2009) 
Poliray 450 Yes No (Lincoln et al., 2006) 
Polilight 310-650 Yes Yes (Tay et al., 2020; Vandenberg & Van 
Oorschot, 2006; An et al., 2015) 
LumatecⓇ 
Superlight 400 
320-700  Yes  Yes (An et al., 2015; Virkler & Lednev, 2009; 
Zapata et al., 2015) 
 
SEM-EDX  
Electron microscopy is used to create high resolution imagery for biological and 
nonbiological substances. Scanning electron microscopy (SEM) is the most common type of 
electron microscopy. With SEM, the microscopic structure of an item is examined by scanning 
its surface using a high resolution and a large depth of field (Leng, 2013). SEM can be used to 
visualize spermatozoa (Nussdorfer, Cilenšek, Zorn, & Petrovič, 2018). When coupled with an 
energy dispersive X-ray (EDX) microanalysis detector, characteristic elemental components of a 
body fluid can be detected (Lászik et al., 1999). This method can be used to detect multiple body 
fluids, including semen and saliva (Quinton, 1978). Detection of zinc, sodium, phosphorus, 
sulfur, chlorine, potassium, calcium, etc., is used to indicate the presence of a semen or saliva 
and other body fluids (Lászik et al., 1999; Virkler & Lednev, 2009). The quantity of each 
element varies from body fluid to body fluid. The identification and distinction of an unknown 
stain will rely on the ratio of the elements (Virkler & Lednev, 2009). This method cannot be used 
for body fluid mixture analysis. This method requires a clean surface for optimal results, and it 
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experiences interference from the stain’s substrate (Nussdorfer et al., 2018; Virkler & Lednev, 
2009). 
Choline Detection for Semen 
Chemical and enzymatic tests used to determine the presence of semen and saliva are 
based on their composition (Harbison & Fleming, 2016). Choline is an essential nutrient that can 
be found in human semen at a concentration of 0.9 – 1.4 mg/ml (Takatori, Tomii & Tanaka, 
1981). Choline is used as a biomarker for semen. The Florence test is used to indicate the 
presence of choline. The Florence test is a microchemical crystal test that utilizes a solution of 
iodine and potassium to form brown needle-like crystals in the presence of choline (Virkler & 
Lednev, 2009; Zapata et al., 2015). Due to the low sensitivity of this method, false negative 
results are common (Virkler & Lednev, 2009). Normal levels of choline in other body fluids, 
including vaginal fluid, and semen from other animals cannot be detected utilizing this method 
(Takatori et al., 1981; Virkler & Lednev, 2009).  
A chemiluminescent test can also be used to detect choline (Virkler & Lednev, 2009; 
Zapata et al., 2015). This method involves the use of a choline oxidase and luminol solution. 
Luminol combined with choline oxidase becomes luminescent in the presence of choline. 
Isotachophoresis, a type of electrophoresis that implements separation based on ionic mobility, is 
also used to detect choline on a stain (Virkler & Lednev, 2009). This method produces no false 
positives, can be used for old stains, and can detect semen from vaginal swabs collected from 
deceased victims (Virkler & Lednev, 2009). 
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Acid phosphatase Detection for Semen 
Acid phosphatase is an enzyme and major component of semen. It is used as a biomarker 
for semen. The traditional acid phosphate test involves a reaction between the semen stain, or an 
extract placed on a filter paper, a chemical substrate—monophenolic phosphoric acid or its 
derivatives—and a pH 5 acetate buffer (Raju & Iyengar, 1964). The acid phosphatase hydrolyzes 
the substrate, forming phenol and phosphate ions. The phenol formed reacts with a diazonium 
salt and produces a colored compound (Raju & Iyengar, 1964; Zapata et al., 2015). 
Amylase Detection for Saliva 
High levels of alpha-amylase 1 can be found in human saliva; hence, it is utilized for 
saliva detection. Amylase catalyzes the digestion of starch. Therefore, a starch-iodine test is 
used. Starch reacts with iodine to form a blue compound, but in the presence of salivary amylase, 
this color change does not occur because the amylase consumes the starch (Zapata et al., 2015; 
Hedman, Dalin, Rasmusson & Ansell, 2011; Virkler & Lednev, 2009). This test is not specific 
for saliva because it can provide positive results for blood and semen (Virkler & Lednev, 2009). 
Another amylase detection method involves the Phadebas® test reagent, which is largely 
composed of procion red amylopectin (Virkler & Lednev, 2009). Phadebas® takes advantage of 
amylase’s starch digesting activity and includes a starch complex with an attached color 
molecule, which is released when the amylase breaks down the starch (Hedman, Gustavsson, & 
Ansell, 2008). This method can detect saliva that has been diluted 1:128; however, it is positive 
for urine, feces, face lotion, hand cream, and washing powders (Virkler & Lednev, 2009).  
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Prostate Specific Antigen Detection for Semen 
Prostate specific antigen (PSA) or P30 is a glycoprotein secreted into the seminal plasma 
(Hochmeister et al., 1999). It is a biomarker for detecting human semen and is effective for 
semen deposited by individuals that are vasectomized or azoospermic (Hochmeister et al., 1999). 
Techniques used to detect PSA include rocket immunoelectrophoresis, enzyme-linked 
immunosorbent assay (ELISA), Ouchterlony double diffusion, radial immunodiffusion, 
crossover electrophoresis and immunochromatographic test strip (such as ABA card and 
Biosign® PSA) (An et al., 2015; Hochmeister et al., 1999; Zapata et al., 2015). All of these 
methods depend on the interaction of PSA and its antibody and they are used as confirmation 
(Virkler & Lednev, 2009; Zapata et al., 2015). Published works discuss the presence of PSA at 
low levels in other body fluids, such as urine and breast milk (An et al., 2015). 
Microscopic Visualization of Spermatozoa 
 Microscopic visualization is used to detect spermatozoa by Christmas tree staining. 
Christmas tree staining involves the use of a nuclear fast red dye and picroindigocarmine (Bell, 
2012). The nuclear fast red dye will turn the head red, while the picroindigocarmine will turn the 
tail green (Ispan, 2018; Virkler & Lednev, 2009; Zapata et al., 2015). Another method includes 
the addition of proteinase K, which denatures the epithelial cells and makes the head more 
vibrant (Virkler & Lednev, 2009). Christmas tree staining is limited in the fact that the semen 
donor must have sperm present; therefore, it does not work for donors that have been 
vasectomized or are azoospermic (Virkler & Lednev, 2009). Enhanced microscopy utilizes 
human spermatozoa specific antibodies coupled to a fluorescent dye (Miller et al., 2011). This 
very selective staining technique can be combined with laser microdissection for separating 
sperm cells from vaginal epithelial cells (Miller et al., 2011).  
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New Body Fluid Techniques  
Raman 
Raman spectroscopy is an analytical chemistry method that is rapidly gaining popularity 
in the forensic discipline (Schlagetter, Kammrath, & Glynn, 2017). Raman spectroscopy is a 
nondestructive method that is based on the inelastic scattering of a low-intensity laser light when 
it comes into contact with a sample (Harbison & Fleming, 2016; Virkler & Lednev, 2008). This 
technique requires little to no preparation and only picograms or femtoliters of the sample is 
needed (Virkler & Lednev, 2008). Raman spectroscopy shows little water inference, and 
therefore, can be used to analyze body fluids and their stains (Virkler & Lednev, 2008). The 
resultant Raman spectra are composed of multiple narrow bands that create a unique vibrational 
signature of the molecular structure of each body fluid (Harbison & Fleming, 2016; Virkler & 
Lednev, 2008). Body fluid analysis using Raman spectroscopy requires complex statistical 
analysis due to the heterogeneous nature of dry stains and variation among individuals (Harbison 
& Fleming, 2016). Unique vibrational Raman spectra have been determined for various body 
fluids, including semen and saliva (Sikirzhytski, Virkler, & Lednev, 2010). 
X-ray fluorescence  
X-ray fluorescence (XRF) is an imaging technique that is being implemented for forensic 
applications. XRF has been successfully utilized for the detection of semen (Zapata et al., 2015). 
XRF imaging involves the application of a micro-focused X-ray beam incident to different parts 
of the sample to develop an image (Pushie, Pickering, Korbas, Hackett, & George, 2014). The 
XRF is monitored by an energy dispersive detector (Pushie et al., 2014). National Aeronautics 
and Space Administration (NASA) technology is being used to create a portable XRF devise that 
can be used at the crime scene to detect abundant components of semen, as well as blood (Carr, 
 10 
2009). This method is useful because it is nondestructive; however, it does not produce 
confirmatory results due to its lack of specificity (Carr, 2009).  
Nuclear magnetic resonance  
Nuclear magnetic resonance is an emerging analytical tool for identification and 
quantification of different metabolites, in body fluids and other complex mixtures, without the 
need for laborious sample preparation (Rai & Sinha, 2012). The metabolic composition of each 
body fluid yields a unique spectrum that can be used to distinguish one from the other (Harbison 
& Fleming, 2016). This method requires a series of complex statistical processes, considering 
donor to donor variability, in order to interpret the characteristic NMR profile produced for each 
body fluid (Harbison & Fleming, 2016). Nonetheless, NMR spectroscopy is advantageous 
because it doesn’t focus on one chemical property of the body fluid but rather the metabolite 
profile as a whole, and therefore, gives rise to a ‘metabolite fingerprint’ (Scano et al., 2013). The 
unique spectra produced can be compared to spectra of samples from unknown origin for 
identification purposes and mixture analysis (Harbison & Fleming, 2016). 
mRNA 
 Messenger ribonucleic acid (mRNA) profiling is a new method that has been investigated 
as an alternative to traditional body fluid identification assays (An et al., 2015; Harbison & 
Fleming, 2016; Ingold et al., 2018; Richard et al., 2012; Zapata et al., 2015). mRNA profiling 
depends on the individual expression of mRNAs that occurs due to the different mRNA 
sequences in different body fluid cell types (Ingold et al., 2018; Park et al., 2013; Richard et al., 
2012; Sijen, 2015; Zapata et al., 2015). Targeting a mRNA transcript depends on the amount of 
transcript present, as well as the stability of each transcript in the body fluid cell; hence, different 
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mRNA markers have different sensitivities (Harbison & Fleming, 2016). mRNA profiling and 
traditional presumptive tests have similar limits of detection (Harbison & Fleming, 2016).  
RNA is less stable, compared to DNA; however, studies have shown that mRNA is stable 
in body fluid stains found on various surfaces (An et al., 2015; Harbison & Fleming, 2016). A 
big advantage of mRNA profiling is that mRNA and DNA can be simultaneously extracted from 
the same stain (An et al., 2015; Harbison & Fleming, 2016; Lindenbergh, Maaskant, & Sijen, 
2013; Richard et al., 2012). However, mRNA profiling is arduous and more expensive than other 
body fluid identification methods (Lindenbergh et al., 2013). 
Reverse transcriptase polymerase chain reaction (RT-PCR) is a novel and sensitive 
method used to detect low-abundance mRNA isolated from biological stains (Harbison & 
Fleming, 2016). The method was first introduced in 2005 by Juusola and Ballantyne (2005; 
Harbison & Fleming, 2016). They proposed a RT-PCR based multiplex assay for the 
identification of body fluids common to forensic casework (An et al., 2015; Juusola & 
Ballantyne, 2005). The method exhibited sufficient sensitivity and detection was successful for 
200 picograms to 12 nanograms of RNA (An et al., 2015; Juusola & Ballantyne, 2005). In 2007, 
Juusola and Ballantyne developed a multiplex utilizing a quantitative RT-PCR (qRT-PCR) assay 
(2007; An et al., 2015). The qRT-PCR assay calculates the difference between a reference 
housekeeping gene (∆CT) and the desired RNA transcript (Harbison & Fleming, 2016; Juusola 
& Ballantyne, 2007) . This method uses numerical thresholds because it is highly sensitive 
(Harbison & Fleming, 2016; Juusola & Ballantyne, 2007). A problem that is commonly faced 
with this method is that there is a restriction on the dyes that can be used, and therefore, there is a 
limited number of markers that can be targeted in a single reaction (Harbison & Fleming, 2016). 
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High-resolution melting analysis has been proposed as a solution for the limitation (Harbison & 
Fleming, 2016).  
In 2018, European Forensic Genetics (EUROFORGEN) and European DNA Profiling 
Group (EDNAP) worked on a collaborative method for mRNA-targeted body fluid identification 
utilizing massively parallel sequencing (MPS) (Ingold et al., 2018). With this sequencing 
method, a multiplex of markers can be detected in a single reaction, saving time and sample 
consumption. There is also potential for quantitative analysis due to a larger dynamic range, and 
the resolution of mixtures due to the ability to identify mRNA sequence variation (Ingold et al., 
2018). 
microRNA  
 mRNA markers can be used for successful and specific body fluid identification and have 
been proven to be stable for a long period of time. However, environmental conditions, such as 
humidity and hot climate, can influence mRNA stability and lead to degradation (An et al., 
2015). Micro RNA (miRNA) markers have proposed as an alternative tool because they are 
smaller RNA molecules and less susceptible to degradation (An et al., 2015). miRNAs are non-
coding molecules that are about 18-22 nucleotides long and regulate post-transcriptional gene 
expression (An et al., 2015). Body fluid identification utilizing mRNA relies on the fact that 
many miRNA molecules are tissue-specific; therefore, these molecules can be body fluid specific 
(An et al., 2015). 
 The first assay using miRNA as a biomarker was conducted by Hanson, Lubenow, & 
Ballantyne (2009; An et al., 2015; Van Steendam et al., 2013). In their study, they examined 
miRNA expression in body fluids common to forensic casework (Hanson et al., 2009). miRNA 
analyses are conducted using the same techniques as mRNA assays, i.e. RT-PCR (Sijen, 2015). 
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Creating a multiplex assay is very difficult because there are a small number of dyes available 
for miRNA-based RT-PCR assays (Van Steendam et al., 2013). 
DNA methylation 
 DNA methylation is also being investigated for body fluid identification. DNA 
methylation is an epigenetic modification that consists of the addition of a methyl group to the 5’ 
position of cytosine in CpG dinucleotide (Yuan, 2014; An et al., 2015; Harbison & Fleming, 
2016). Whole-epigenome studies have shown that DNA undergoes tissue specific methylation 
patterns (An et al., 2015; Van Steendam et al., 2013). The analysis and detection of the tissue-
specific methylation patterns can be applied to body fluid identification, in which body fluid 
specific cell methylation patterns are examined (An et al., 2015; Frumkin, Wasserman, Budowle, 
& Davidson, 2011; Van Steendam et al., 2013). The first reported method was developed by 
Frumkin et al. (An et al., 2015; Van Steendam et al., 2013). The detection of the methylation is 
conducted by using methylation-dependent restriction enzyme followed by PCR and/or bisulfite 
sequencing (Harbison & Fleming, 2016). This method can be combined with current STR typing 
assays to reduce sample consumption and time (Frumkin et al., 2011; Van Steendam et al., 
2013). Nonetheless, in order to make DNA methylation applicable for casework, more markers 
need to be identified (An et al., 2015). 
Proteomics 
 A proteomics-based method for body fluid identification has proven to be very promising 
because it is based on the detection of various high-specificity protein biomarkers (Legg et al., 
2017). Unlike DNA, proteins can be found in abundance within the cell. They are also more 
stable than RNA. When creating a body fluid identification assay, the main goal would be to 
identify signature proteins, which are unique to the specific body fluid. Many studies have been 
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done to determine candidate biomarkers (Kamanna et al., 2016; Legg et al., 2014, 2017; Van 
Steendam et al., 2013; Yang et al., 2013). Table 3 presents a list of the most common protein 
biomarkers identified in published studies.  
Identification of proteins is conducted using a separation method—high performance 
liquid chromatography—followed by an analytical method, such as mass spectrometry 
(Aebersold & Mann, 2003). There is a size limitation for mass spectrometry, so protein is usually 
digested to peptide fragments (Aebersold & Mann, 2003). Due to advances in mass 
spectrometry, proteins in complex samples can be identified, categorized, and quantified at high 
sensitivity (Domon & Aebersold, 2006). Additionally, mass spectrometry offers the advantage of 
multiplex analysis with high accuracy and specificity (Legg et al., 2017). 
  
 15 
Table 3: Suggested protein biomarkers for semen and saliva identification*  





Semen Semenogelin 1 (SEMG1) P04279 IPI00023020 
Semenogelin 2 (SEMG2) Q02383 IPI00025415 
Prostate-specific antigen (KLK3) P07288 IPI00010858 
Prostatic acid phosphatase (ACPP) P15309 IPI00396434 
Saliva Alpha-amylase 1 (AMY1A) P04745 IPI00300786 
Histatin-1 (HTN1) P15515 IPI00012024 
Cystatin_SA (CST2) P09228 IPI00013382 
Cystatin_D (CST5) P28325 IPI00002851 
Statherin P02808 IPI00022990 
Submaxillary gland androgen 
regulated protein 3B 
(SMR3B_HUMAN) 
P02814 IPI00023011  
* information based on Kamanna et al., 2016; Legg et al., 2014, 2017; Van Steendam et al., 
2013; Yang et al., 2013 
Liquid Chromatography Mass Spectrometry  
Reverse-Phase High Performance Liquid Chromatography  
High-performance liquid chromatography (HPLC) is a separation method based on 
polarity (Aguilar, 2004). In reversed phase HPLC, the stationary phase is nonpolar, whereas the 
mobile phase is polar. Nonpolar molecules in the mobile phase will adsorb to the stationary 
phase, while polar molecules will have a stronger affinity for the mobile phase, and therefore, 
will pass through the column and elute first (Aguilar, 2004). Isocratic elution can occur, where 
the composition of the mobile phase is constant throughout the run. A gradient elution may also 
occur, in which the composition of the mobile phase varies increasing its elution strength 
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throughout the run. RP-HPLC is a very effective separation method for peptides and proteins and 
is commonly used in combination with mass spectrometry for body fluid identification (Domon 
& Aebersold, 2006; Legg et al., 2014, 2017; Van Steendam et al., 2013).  
Mass Spectrometry 
Mass spectrometry is a technique used to produce qualitative and quantitative data for an 
ionized analyte (Ho et al., 2015). The analyte is ionized by passing through an ionization source 
to acquire a negative or positive charge. The ions are then introduced to a mass analyzer and 
finally to the detector according to their mass-to-charge ratios (Ho et al., 2015). 
Ionization 
The development of ionization techniques such as electrospray and matrix assisted laser 
desorption ionization revolutionized mass spectrometry and made it applicable for the analysis of 
large biological molecules, such as proteins (Singhal, Kumar, Kanaujia, & Virdi, 2015). Both 
ionization techniques utilize soft ionization to convert peptides into ions by adding or removing 
one or more protons (Singhal et al., 2015). In soft ionization, ion formation does not result in 
significant fragmentation (Singhal et al., 2015). 
Matrix assisted laser desorption/ionization (MALDI) is implemented for biological 
samples that cannot be analyzed using hard ionization methods. Initially, a solution of the sample 
and the matrix, an organic energy-absorbent compound, is created. The sample is ionized in the 
matrix with a laser beam. Desorption and ionization occur with the laser to produce protonated 
ions of the analytes (Singhal, Kumar, Kanaujia & Virdi 2015).  
Electrospray ionization (ESI) is a soft ionization method used to produce gas phase ions 
without fragmentation (Banerjee & Mazumdar, 2012). In ESI, a continuous stream of the sample 
is passed through a capillary tube, which is maintained at a high potential (Ho et al., 2015). The 
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sample is nebulized using a flow of nitrogen gas. Ionization of the sample occurs in three steps: 
1) dispersal of a mist composed of charged droplets, 2) evaporation of the solvent, and 3) 
ejection of the ion from the highly charged droplets (Ho et al., 2015). The charged droplets, 
produced at the end of the electrospray tip, travel along a pressure and potential gradient, 
towards the mass analyzer (Ho et al., 2015). With the assistance of a stream of nitrogen gas, the 
charged droplets undergo evaporation and decrease in size (Ho et al., 2015).  This leads the 
droplets to increase in surface charge density and decrease in radius (Ho et al., 2015).  When the 
electric field strength reaches a critical point, the ions at the surface of the droplets are ejected 
into the gaseous phase (Ho et al., 2015). The ions that are emitted are then accelerated into the 
mass analyzer (Ho et al., 2015). 
Mass Analyzers 
The mass analyzer is the component of a mass spectrometer that separates the ions based 
on mass-to-charge (m/z) ratios. There are two categories of mass analyzers: low and high 
resolution. Mass resolution describes the separation that occurs in a mass spectrum (Gross, 
2011). Mass resolution is represented as the smallest difference in mass-to-charge that can be 
fully separated for a given signal (Gross, 2011). Higher resolution results in narrower and 
sharper peaks in the spectrum. Mass resolution is also a reflection of mass resolving power 
(Marshall & Hendrickson, 2008). Mass resolving power is expressed as a ratio between the mass 
(m) and the width of the peak at a height that is a certain fraction of the maximum peak height 
(dm), see Figure 1 (Macherone, 2013). Mass resolution and mass resolving power are directly 
proportional. Higher resolution instruments have higher resolving power.  
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Figure 1: A diagram displaying mass resolving power factors for determining resolution of a 
peak at a given ion, where m is the m/z 400 and dm is 50% of the maximum peak. 
Time-of-flight (ToF) is a high-resolution mass analyzer with a resolving power that 
usually exceeds 12,000 (Domon & Aebersold, 2006). ToF analyzers are usually used for 
proteomic, with MALDI as the ionization source. For ToF analyzers, ions are separated by the 
time they take to travel through a flight tube, which is under a vacuum with an applied fixed 
voltage (Domon & Aebersold, 2006). This technique operates in scan mode in which the full 
mass range is examined, and all mass-to-charge ratios are determined. 
 The quadrupole is a low-resolution mass analyzer that acts as a mass filter. The system is 
composed of four metal rods that are parallel and at equidistance (Ho et al., 2015). The rods have 
fixed direct current (DC) and alternating radiofrequency voltages applied to them (Ho et al., 
2015). An electrical field is produced, and the ions are focused and passed through the middle of 
the quadrupole rod in an oscillating motion (Ho et al., 2015). The motion or oscillation of the 
ions will depend on the electric field. Only ions of a specified m/z will be in resonance with the 
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electrical field and permitted to pass through. This system can function in scan mode and 
selected-ion monitoring (SIM) mode. In SIM mode, only ions of a pre-determined m/z can pass 
through the quadrupole. 
Tandem Mass Spectrometry 
Tandem mass spectrometry (MS/MS) utilizes two mass analyzers. The most common 
system employs two quadrupoles with a collision cell separating both quadrupoles (Mittal, 
2015). This technique is known as triple quadrupole (QqQ). The first quadrupole is used to 
determine or target the precursor ion. Next, the precursor ions migrate through the collision cell, 
where they are bombarded with an inert gas and undergo fragmentation to produce product ions. 
The product ions are then determined or targeted by the second quadrupole. This system can 
undergo a product scan when the first quadrupole is static, and the second quadrupole is in 
scanning mode (Ho et al., 2015). A precursor scan can be conducted when the first quadrupole is 
in scanning mode and the second quadrupole is static (i.e. in SIM mode) (Ho et al., 2015). The 
system can also undergo a neutral loss scan, in which both quadrupoles are in scanning mode. 
Multiple reaction monitoring (MRM) can be utilized when both quadrupoles are static (Ho et al., 
2015).  
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Figure 2: Schematic diagram of a triple quadrupole system using electrospray ionization. This 
MS consists of two quadrupole mass analyzers, which act as mass filters and a radiofrequency 
only quadrupole, which causes fragmentation of the analyte through interaction with a collision 
gas. 
Aim of Research 
The aim of this study is to develop a peptide-based method using LC-MS/MS for body 
fluid identification. We hypothesize that tandem low-resolution mass spectrometry can be 
implemented for reliable, semi-quantitative signature peptide detection. The specific goals are 1) 
to establish an assay using tandem low-resolution mass spectrometry in MRM mode, 2) to 
simultaneously analyze DNA, and 3) to validate the established assay. The MRM parameters for 
each peptide will be determined by analyzing synthetic peptides. Those parameters will then be 
applied to authentic samples. Method validation will include analyses to determine the peptides’ 
minimum sample volume, repeatability of the peptide signal, assay compatibility with different 
substrates, and how the peptides can be detected in a mixture.   
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Methods and Materials  
Sample Collection and Preparation 
Semen was purchased from a commercial provider (Lee Biosolutions, Maryland Heights, 
MO). Saliva was collected from volunteers after CUNY IRB approval (#2017-0080). For the 
collection process, the volunteers were required to rinse their mouths only if they ate an hour 
prior to the collection process. Each volunteer was asked to provide at least 1 mL of saliva in 15 
mL Eppendorf plastic centrifuge tubes (Hamburg, Germany).  
Five µL of semen and saliva were spotted on swabs—cotton (Puritan), polyester 
(Fisherbrand, Thermo Fisher Scientific, Waltham, MA) and CEP (Fitzco, Spring Park, MN)—
and white cotton t-shirt, black cotton t-shirt, blue denim, tissue paper, and polyester t-shirt. The 
tips of each swab were cut off. The other substrates were cut into circular pieces with diameters 
of approximately 0.5 cm. Cotton swabs and t-shirts stains containing 10 µL of semen, produced 
in 2014, were cut in half to estimate for 5 µL.  
Liquid semen and saliva were used to create mixed stains on cotton swabs and t-shirts. To 
make mixed solutions, semen and saliva were added at the following ratios (v/v): 1 to 1, 1 to 2, 2 
to 1, 1 to 5, and 5 to 1. Five µL of each mixture was placed on the appropriate substrate. 
Standard Preparation 
Saliva and semen signature peptides were chosen based on Legg et al. (2017), the 
Universal Protein Resource (UniProt), and PROWL Protein Info. Five peptides for saliva and 
semen were analyzed. For semen, semenogelin-1 was chosen as the biomarker and two signature 
peptides were targeted: SEMG1-pep1 and SEMG1-pep2. For saliva, submaxillary gland 
androgen regulated protein 3B (SMR3B) and histatin-1 were the biomarkers. One peptide was 
targeted for histatin-1, HIST 1, and two peptides were targeted for SMR3B, SMR3B-pep1 and 
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SMR3B-pep2. See Table 4 for the peptides’ sequences and additional information. Synthetic 
peptides were obtained from Genscript (Piscataway, NJ). To prepare stock solutions of each 
peptide, 1 mg of the peptide was added to 1000 µL of the appropriate solvent. All of the 
synthetic peptides were dissolved in irradiated reversed osmosis water with the exception of 
SEMG1-pep2, which was dissolved in 0.1M ammonium bicarbonate.  
Synthetic peptide standards were prepared by mixing all five peptides at a concentration 
of 50 nmol/mL and creating five 1:10 serial dilution steps down to 0.005 nmol/mL. A study to 
determine the cutoff for each synthetic peptide was conducted, in which mixtures containing all 
five peptides were prepared at the following concentrations: 0.001, 0.0025, 0.005, 0.01, 0.025, 
0.05, and 0.1 nmol/mL.  
Table 4: Semen and saliva signature peptides with corresponding sequences, charges, and stock 
solvents. 
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The incubation buffer consisted of 1% ProteaseMax™ surfactant (Promega, Madison, 
WI), 0.5 dithiothreitol (DTT) (Promega, Madison, WI), and freshly prepared 50 mM ammonium 
bicarbonate. ProteaseMax™ surfactant is a trypsin enhancer used to ensure maximum efficiency 
of the protease. DTT is used to disrupt the cell membrane and the protein disulfide bonds. The 
ammonium bicarbonate, which is commonly used to buffer trypsin digestions, must be fresh, 
(prepared within three days). The liquid (5 µL) or stain samples were placed in 100 µL of the 
buffer and incubated for 20 min at 56°C, while shaking at 1400 rpm. Three µL of iodoacetamide 
(IAA) (Sigma Aldrich, St. Louis, MO) was added to the solution. IAA is an alkylation base used 
to maintain the separation of the disulfide bonds. This mixture was then placed in the dark for 30 
min at room temperature. One µL of DTT was placed into the solution to deactivate IAA and 
prevent overalkylation. One µL of a 0.1 µg/µL solution of trypsin (Promega, Madison, WI) was 
placed into the solution, which was incubated for 3 h at 37°C and 1400 rpm. Trypsin is an 
enzyme used to cleave other proteins after a lysine and arginine residue, if not followed by a 
proline residue. After the digestion, the trypsin was deactivated by incubating in a stationary heat 
block at 99°C for 10 min and cooling at 4°C for 10 min. See Table 5 for the main modifications 
that were tested. 
To remove the substrates, each digest was decanted into a spin basket placed inside a 
dolphin tube (MIDScientific, Valley Park, MO) and spun down for 5 min at 1500 rcf. The 
samples were stored at -20°C.  
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Table 5: Trypsin digestion modifications that were tested and changed from Overnight with IAA 
protocol. 
Removal of Alkylation Step The addition of IAA and the extra DTT was omitted to 
shorten the digestion process. 
Incubation Time Variation The solutions were incubated in the trypsin digestion buffer 
overnight, approximately 16 h or for 3 h, at 37C and 1400 
rpm. 
 
HyperSep™ SpinTip Extraction and Concentration Method 
The HyperSep™ C18 SpinTip (Thermo Fisher Scientific, Waltham, MA) was 
conditioned by dispersing the releasing (0.1% formic acid and 60% acetonitrile) and the binding 
(0.1% formic acid) solutions through the column using centrifugation at 1500 rcf. The substrate-
free digests were passed through the columns using air pressure via a syringe. The columns with 
the immobilized peptides were washed using the binding solution. The peptides were released 
using the releasing solution. The final solution was evaporated using a TurboVap® LV 
Automated Evaporated System (Biotage, Charlotte, NC) and reconstituted in 50 L. To determine 
the best solvent for the instrumental analysis, C18 extractions were done utilizing water, 60%, 
40%, 20% acetonitrile, and the digestion buffer solution as the reconstitution solvents.   
Nanofiltration Method Purification Method 
The digests were filtered with nano|Filter Vial PVDF 0.2μm (Thomson Instrument 
Company, Oceanside, CA). One hundred µL of the digest was placed into the vial. The screw-
capped component of the nano|Filter was positioned into the vial and pressed down using hand 
pressure to slowly deposit the digest through the filter. 
Peptide and DNA Co-Extraction Purification Method 
 25 
The substrate-free digests were placed on Microcon® MW100 DNA Fast Flow tubes 
membrane units (Millipore, Burlington, MA) and centrifuged for 20 min at 500 rcf. The initial 
flow through (peptide fraction) was stored at -20oC. The DNA fraction remains on top of the 
membrane. To recover the DNA fraction, 20 µL of sterile nuclease free water was placed into the 
inverted membrane unit, which was centrifuged for 3 min at 1000 rcf. The DNA fraction was 
immediately stored at 20oC. 
DNA Quantification 
Extracted DNA was quantified using the Applied Biosystems® Quantifiler™ Trio DNA 
Quantification kit (Life Technologies, Thermo Fisher Scientific, Waltham, MA) on the 
QuantStudio™ 5 Real-Time PCR Systems (Applied Biosystems®, Thermo Fisher Scientific, 
Waltham, MA) utilizing a virtual curve. The virtual curve was prepared using the following 
standards and concentrations (Table 6). 




Standard 1 50 
Standard 2 5 
Standard 3 0.5 
Standard 4 0.05 
Standard 5 0.005 
  
The standards were prepared through serial dilutions as instructed by the manufacturer. A 
master mix was prepared consisting of Quantifiler THP PCR Reaction Mix and Quantifiler Trio 
Primer Mix at a 5 to 4 ratio. Nine µL of the master mix was placed into the appropriate wells in a 
96 well optical plate. Followingly, 2 µL of the negative controls and standards were added to the 
desired positions. The plate was sealed with an adhesive cover using a wedge tool and spun 
down before placing it in the QuantStudio and amplifying as shown in Table 7.  
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 Table 7: Quantifiler Trio real time PCR cycling parameter for 30 cycles 
Initial 
Incubation 



















Polymerase chain reactions (PCR) were conducted utilizing GlobalFiler™ PCR 
Amplification Kit (Applied Biosystems®, Thermo Fisher Scientific, Waltham, MA). To conduct 
half volume reactions, at most 500 pg of the DNA extracts were utilized. The Master Mix and 
Primer Set were added at a 3.75 to 1.25 µL ratio. The positive control was diluted to 100 pg by 
adding 5 µL of the DNA control to 2.5 µL of 0.1X Tris-EDTA buffer. Seven and a half µL of the 
negative control, positive control, and DNA extracts were added to the Master Mix and Primer 
Set solution. A Veriti® 96-Well Thermal Cycler (Applied Biosystems®, Thermo Fisher 
Scientific, Waltham, MA) and conditions shown in Table 8 were used. 
Table 8: Globalfiler Trio thermal cycler cycling parameter for 29 cycles.    
Initial 
Incubation 
















Capillary Electrophoresis and STR Analysis 
An Applied Biosystems™ 3500 Genetic Analyzer was utilized for the capillary 
electrophoresis. A master mix consisting of 600 LIZ size standard v2.0 and Hi-Di™ formamide 
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(Applied Biosystems®, Thermo Fisher Scientific, Waltham, MA) was made at a 0.36 to 10 µL 
ratio. Ten µL of the master mix was placed into pre-identified wells of an Applied Biosystems® 
MicroAmp® Optical 96-Well Reaction Plate (Thermo Fisher Scientific, Waltham, MA). 
Referring to a labelled plate map, 1.2 µL of PCR product, allelic ladder, as well as, positive and 
negative control were loaded into the designated wells. Empty wells within a column were filled 
with 10 µL of Hi-Di™ formamide. The reaction plate was sealed with a septum and briefly 
centrifuged to collect all of the content to the bottom. The plate was placed into the GeneAmp® 
9700 PCR System (Applied Biosystems®, Thermo Fisher Scientific, Waltham, MA) and set to 
denature at 95oC for 5 min and chill at 4oC for 5 min. The reaction plate was centrifuged again 
and loaded on the 3500 Genetic Analyzer (Applied Biosystems®, Thermo Fisher Scientific, 
Waltham, MA). The length of the capillary was 36 cm using human identification (HID) and 
POP4 polymer for a 96 well reaction. The GF+Norm_POP4 assay was used. The raw sizing data 
were converted into allelic calls using GeneMarker® HID (SoftGenetics, State College, PA). 
Peptide Analysis by LC-MS/MS 
The purified or filtered peptide digests were analyzed using a Liquid Chromatograph 
Mass Spectrometer (LC-MS/MS), LCMS-8050 Triple Quadrupole, from Shimadzu (Columbia, 
MD). The ion source employed was electrospray ionization in positive mode (ESI+). Peptides’ 
multiple reaction monitoring (MRM) optimization was performed by direct injection into the MS 
of 1-2 µL of each peptide individually at 5 pmol/ µL. The MRM transitions are shown in Table 
14. The MS source conditions were as follows: nebulizing gas 2 L/min; heat and drying gas both 
at 10 L/min; interface temperature 400°C; DL temperature 250°C; heat block temperature 400°C. 
The chromatographic separation was performed onto an Agilent AdvanceBio Peptide mapping 
column (100 mm X 2.1 mm I.D., 2.1µM) protected with an Agilent guard column of similar 
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chemistry than the column (Santa Clara, CA) utilizing a flow rate of 0.5 mL/min at 55oC column 
temperature. A gradient consisting of water and 0.1% formic acid (mobile phase A) and 
acetonitrile and 0.1% formic acid (mobile phase B) was utilized. The gradient sequence was as 
follows: 0-20 min, 5-40% B; 20-21 mins, 40-95% B; 21-24 min, 95%B; 24-25 min, 95-5%B; 25-
30 min, 5%B. The injection volume was 20 µL. 
Statistical Methods 
 To determine the variation between the different digestion methods, variance values were 
obtained using the following equation: 
 
where x equals the value, µ equals the mean, and n is the sample size. Variance can also be 
expressed as σ2, where σ is the standard deviation. To test for repeatability in the peptide signals, 
relative standard deviation values were determined with a sample size of n=30. The following 
equation was used: 
 




Results   
Peptide Results 
Trypsin Digestion Modifications 
Different digest modifications were tested. The original procedure involved an overnight 
trypsin digestion based on a standard proteomics protocol provided by Dr. Zhe Cheng from the 
Weill Cornell Medicine Proteomics core facility in New York City (personal communication). 
That method was then modified by omitting the incubation with IAA, which alkylates free S-H 
groups and prevents reannealing of reduced disulfide bonds. For this modification we also added   
additional DTT to prevent overalkylation. In a third modification, the IAA step was left in place, 
but the duration of the trypsin digestion was reduced from overnight to 3-hour. Five donors were 
analyzed for saliva with each procedure. Table 9 displays a comparison of the three 
modifications for saliva.  
The averages show that the removal of the alkylation step diminished the overall 
recovery of all three peptides. The values and standard deviations for each modification also 
reveal a high degree of variation from donor to donor. Donor 1 showed the highest values for 
most markers, especially for the 3-hour digestion methods, here the SMR3B values for both 
peptides were marked as outliers.  Comparing the overnight and 3-hour digestion the HIST1 
peptide only showed a small concentration increase. For both SMR3B values, the across donor 
average increase for the 3-hour digestion was above the upper standard deviation.   
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Table 9: Saliva peptide recovery for three trypsin digestion modifications*  






Overnight with IAA DONOR 1 4.250 5.380 11.230 
Overnight without IAA 0.911 2.390 4.610 
3-hour without IAA 4.153 77.365 34.851 
Overnight with IAA DONOR 2 3.055 2.190 5.473 
Overnight without IAA 0.480 0.850 2.090 
3-hour without IAA 1.097 15.638 11.500 
Overnight with IAA DONOR 3 0.091 0.008 0.024 
Overnight without IAA 0.094 0.022 0.030 
3-hour without IAA 0.043 0.025 0.030 
Overnight with IAA DONOR 4 1.285 0.383 1.122 
Overnight without IAA 0.438 0.815 0.501 
3-hour without IAA 1.427 0.922 1.338 
Overnight with IAA DONOR 5 0.083 0.089 0.401 
Overnight without IAA N/A N/A N/A 
3-hour without IAA 0.294 0.997 0.938 
Overnight with IAA Average 1.753+/-1.851 1.610+/-2.288 3.650+/-4.766 
Overnight without IAA Average 0.481+/-0.335 1.109+/-0.991 1.808+/-2.066 
3-hour without IAA Average 1.403+/-1.638 18.989+/-33.275 9.731+/-14.799 
* outliers in bold 
 
Variance was calculated to determine how far apart the peptide recovery value was for 
each donor, when comparing the three methods. The variance for each donor can be found in 
Table 10. Donors 3, 4, and 5 have the lowest variance value, while Donor 1 has the highest 
value. SMR3B recovery for Donor 1 has the highest variance. As discussed previously, the 3-
hour digestion resulted in a very high recovery for SMR3B peptides in all 5 donors. The 
recovery value for Donor 1 was significantly higher with the 3-hour digestion and were labelled 
as outliers. These outliers lead to a large variance for SMRB peptides in Donor 1.   
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Table 10: Variance between saliva peptide recovery for three trypsin digestion modifications 
 
DONORS HIST1 SMR3B-pep1 SMR3B-pep2 
DONOR 1 3.611 1802.005 252.716 
DONOR 2 1.808 66.888 22.720 
DONOR 3 0.0008 0.00008 0.000009 
DONOR 4 0.286 0.081 0.189 
DONOR 5 0.022 0.413 0.144 
 
The removal of the alkylation step also led to a decrease in semen peptide recovery. Donor 2 
showed the highest recovery values for both markers. The values for SEMG1-pep1, for the 
digestion methods with IAA, were labelled as outliers. Additionally, for donor 4, the value for 
SEMG1-pep2 using the 3-hour digestion was also labeled as an outlier. Donor 5 showed the 
lowest recovery value, and no peptides were detected for one of the modifications, see Table 11. 
For SEMG1-pep2, the 3-hour digestion showed the highest peptide recovery for all donors.  
The variance between the three methods was also calculated for the semen samples (see 
Table 12). For both peptides, donor 5 had the lowest variance, while Donor 2 had the highest 
variance value. The variance for Donor 2 is high because the recovery value for the digestion 
methods with alkylation were labelled as outliers and the digestion without alkylation resulted in 
a very low peptide signal.  
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Overnight with IAA 
DONOR 1 
4.378 42.385 
Overnight without IAA 0.578 1.998 
3-hour without IAA 4.363 52.207 
Overnight with IAA 
DONOR 2 
47.376 245.601 
Overnight without IAA 4.642 3.279 
3-hour without IAA 28.127 324.064 
Overnight with IAA 
DONOR 3 
8.464 14.835 
Overnight without IAA 1.392 0.525 
3-hour without IAA 8.402 20.931 
Overnight with IAA 
DONOR 4 
7.315 67.970 
Overnight without IAA 0.954 2.976 
3-hour without IAA 9.145 255.866 
Overnight with IAA 
DONOR 5 
0.250 2.892 
Overnight without IAA ND^ ND^ 
3-hour without IAA 0.405 8.501 
Overnight with IAA Average 13.557+/-19.170 74.736+/98.789 
Overnight without IAA Average 1.891+/-1.863 2.194+/-1.240 
3-hour without IAA Average 10.088+/-10.673 132.314+/-146.787 
* outliers in bold 
^ not detected 
 
Table 12: Variance between semen peptide recovery for three trypsin digestion modifications 
 
DONOR SEMG1-pep1 SEMG1-pep2 
DONOR 1 4.794 708.088 
DONOR 2 458.055 27963.302 
DONOR 3 16.526 109.722 
DONOR 4 18.482 17247.133 
DONOR 5 0.0417 18.682 
 
Extraction/Purification Methods 
Three different extraction/purification methods were tested on semen swab samples 
(Table 13). The first method utilized was HyperSep™ C18 SpinTip (C18) columns. The C18 
method required multiple steps and was laborious and time-consuming; therefore, a more 
convenient method with a single pass through using nano|Filter vials was also tested. Lastly, in 
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order to conduct both protein and DNA analysis, a co-extraction method was tested using 
Microcon® MW100 membrane tubes. This membrane has a 100kD pore size, retaining the larger 
DNA molecules and any debris in the retentate above the membrane, while the smaller digestion 
products are in the flow-through.   
Liquid and swab semen samples from two donors were used as a positive control to 
evaluate the procedures. A blank sample was set using a negative control that consisted of the 
buffer and extraction reagents. For both donors, the nano|Filter method resulted in a higher 
concentration of both peptides. However, for Donor A, the concentration of SEMG1-pep1 was 
slightly higher using the Microcon method. The nano|Filter and Microcon method produced very 
similar final concentrations of SEMG1-pep1 and SEMG1-pep2 for both donors. The p values for 
SEMG1-pep1 and SEMG1-pep2 are 0.00173 and 0.00058, respectively. Meaning, there was no 
significant difference between the two extraction methods. The C18 method produced peptide 
concentrations that were below the blank sample cut-off, classifying these samples as negative. 
The C18 extraction method lost a significant amount of peptide and led to false negative results. 
Table 13: Nano|Filter , Microcon, and C18 extraction comparison* 









Swab C18 spin 
column (ng/mL) 
SEMG1-pep1 Donor A 15.3 14.1 14.7 0* 
Donor B 64.8 59.1 54.0 0* 
SEMG1-pep2 Donor A 286.9 274.2 237.5 0* 
Donor B 367.6 360.1 335.9 0* 
* The C18 extraction method fell below the cutoff. 
Synthetic Peptide Calibration Curve and Multiplex Analysis by LC-MS/MS 
Synthetic peptides and precursor and product scans were used to determine quantifier and 
qualifier transitions for each peptide (Table 14). For saliva, three peptides were analyzed: HIST1, 
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SMR3B-pep1 and SMR3B-pep2. Two peptides were analyzed for semen: SEMG1-pep1 and 
SEMG1-pep2. The quantifier and qualifier product ions for HIST1 had a m/z of 411 and 136, 
respectively. The m/z for the quantifier and qualifier for SMR3B-pep1 were 614 and 517, 
respectively. For SMR3B-pep2, one quantifier and two qualifiers were identified. The quantifier 
was m/z 628 and the qualifiers were m/z 624 and 438. Both semen peptides had one quantifier 
and one qualifier ions. For SEMG1-pep1, the quantifier was m/z 136 and the qualifier was m/z 
332. Whereas, for SEMG1-pep2, the quantifier and qualifier were m/z 201 and m/z 424, 
respectively. Figure 3 displays the total ion chromatogram (TIC) of all 5 peptides. 
 
Figure 3: An overlaid chromatogram of a mixed sample including all five peptides at 0.05 
nmol/mL (in buffer). 
 
To determine the cutoff for the peptides, mixtures containing all five peptides were 
prepared at the following concentrations: 0.001, 0.0025, 0.005, 0.01, 0.025, 0.05, and 0.1 
nmol/mL in the buffer. SMR3B-pep2 and SEMG1-pep2 had the lowest cutoff, at 0.0025 
nmol/mL. The rest of the peptides showed a cutoff value at 0.005 nmol/mL (Table 15). 
 35 
 
Table 14: LC-MS/MS transitions and retention times for synthetic peptides. Quantifier 
transitions are in bold. 






Hist1 982.5 411.1 13.8 
136.2 13.8 
SMR3B-pep1 1034.8 614.9 14.2 
517.8 14.2 
SMR3B-pep2 711.0 628.4 13.0 
614.4 13.0 
438.3 13.0 
SEMG1-pep1 680.0 136.3 10.3 
332.2 10.3 
SEMG1-pep2 843.0 201.2 12.2 
424.3 12.2 
 









Determination of Minimum Saliva/Semen Volume 
Liquid samples from the semen and saliva donors with the highest (Donor 1) and lowest 
(Donor 2) peptide concentrations as determined above (Tables 9 and 11) were used to test the 
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ability to detect target peptides in different volumes. This experiment establishes the minimum 
sample volume required to detect peptides in semen and saliva; results are shown in Table 16. 
The minimum sample volume for SMR3B-pep2 was not reached for Donor 1. In the case of 
Donor 2, the minimum sample volume was 0.5µL. For the donor with the highest peptide 
concentration the minimum sample volume for HIST1 and SMR3B-pep1 are 0.5µL and 1µL, 
respectively. For Donor 2, the minimum sample volume was 2µL.  
HIST1 was problematic and provided unusual results for Donor 2. As the volume of the 
sample decreased, the concentration of the peptide decreased. This pattern was not observed for 
HIST1 in Donor 2. HIST1 was not detected in the sample volume of 1µL but was detected in the 
sample volume of 0.5µL. Additionally, the concentration of HIST1 was greater in the 0.5µL 
volume than in the 2µL volume. 
For semen, the sample with the highest (Donor 1) and lowest (Donor 2) concentration of 
peptides was detected for all tested volumes. SEMG1-pep1 was detected in all the volumes, for 
both donors. The minimum sample volume for SEMG1-pep2 was not reached for Donor 1. 
Whereas, for Donor 2, the minimum sample volume was 0.5µL. 
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Table 16: Concentration (nmol/mL) of product ions for signature peptides in extracts from 2, 1, 
0.5, and 0.1 µL of saliva or semen.  









2 µL of saliva Donor 1 0.267 0.847 4.728 ND ND 
1 µL of saliva Donor 1 0.176 0.285 3.154 ND ND 
0.5 µL of saliva Donor 1 0.050 ND 0.321 ND ND 
0.1 µL of saliva Donor 1 ND ND 0.079 ND ND 
2 µL of saliva Donor 2 0.050 0.0425 0.438 ND ND 
1 µL of saliva Donor 2 ND ND 0.134 ND ND 
0.5 µL of saliva Donor 2 0.122 ND 0.079 ND ND 
0.1 µL of saliva Donor 2 ND ND ND ND ND 
2 µL of semen Donor 1 ND ND ND 9.618 112.67 
1 µL of semen Donor 1 ND ND ND 8.335 87.403 
0.5 µL of semen Donor 1 ND ND ND 1.965 18.739 
0.1 µL of semen Donor 1 ND  ND ND 0.639 5.058 
2 µL of semen Donor 2 ND ND ND 3.779 2.552 
1 µL of semen Donor 2 ND ND ND 2.360 1.445 
0.5 µL of semen Donor 2 ND ND ND 0.811 0.608 
0.1 µL of semen Donor 2 ND ND ND 0.247 ND 
ND: not detected. 
Repeatability of Peptide Signal in Saliva and Semen 
Five microliter aliquots of liquid semen and saliva were extracted and analyzed in 
triplicate for a total of 30 samples. The relative standard deviation (RSD) was calculated over all 
concentrations. The results are shown in Figure 4. Values over all three extractions were closer 
for semen than saliva, with all RSD values lower than 20% for the triplicates. HIST1 had the 
highest RSD. An RSD above 60% was observed for HIST1 concentrations detected in donors B 
and C. High RSD values close the 40% were also observed for the SMR3B-pep2 concentrations 
in donors C and D. Overall the detection of semen peptides was more consistent within 




Figure 4: A bar graph displaying the relative standard deviation in percent (%RSD) for 5 semen 
and 5 saliva donors (peptide fraction). Please note that Donor A, B, C, D, and E refers to 
different individuals for each sample type. 
Saliva and Semen Peptide Detection on Stains on Different Substrates 
The current assay was tested on various substrates in triplicates (n=48) for both semen 
and saliva peptide detection. Aged semen stains (n=4) were also analyzed to determine if the 
desired peptides would be detected. Five fabric substrates and three swabs were analyzed after 
spotting 5 µL of saliva or semen from different donors. Results are shown in Table 17. This 
multiplex contains three saliva and two semen signature peptides. Two semen and three saliva 
peptides were detected on all fabric and swab substrates, with the exception of blue denim. For 
the first trial, only 2 out of the 3 saliva peptides were detected on blue denim. Both semen 

























Relative Standard Deviation for Semen and Saliva 
Donor A Donor B Donor C Donor D Donor E
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Blue Denim 2.7 2 
Black Cotton 3 2 
Tissue Paper 3 2 
White Cotton 3 2 
Polyester T-Shirt 3 2 
Polyester Swab 3 2 
Cotton Swab 3 2 
CEP Swab 3 2 
2014 Cotton T-Shirt n/a 2 
2014 Cotton Swab n/a 2 
 
Saliva and Semen Peptide Detection in Body Fluid Mixtures  
Stains were made on cotton t-shirts and swabs with 5 L of semen and saliva mixtures in 
the following ratios: 1:5, 1:2, 1:1, 2:1, and 5:1. The mixture study results on white cotton were as 
expected based on the different signature peptides concentrations in saliva and semen (Table 18). 
Higher peptide signals were observed for both body fluids when they were the major component 
of the mixture, and a decrease in signal was observed when they were the minor component. The 
two semen markers were detected for all samples even as a minor component, while HIST and 
SMR3B-pep1 dropped out for the 2:1 (HIST1) and 5:1 (both) mixtures. The same mixture series 
spotted on cotton swabs had different results. No HIST1 target ions were detected for the 1:1 
mixture, all other samples had all expected signals present. The reason for this is unclear. HIST1 
was previously labelled as a problematic marker due to observed inconsistency in its signal. 
HIST1 expression varies in individuals; however, the same saliva donor was used to make the 
mixtures for cotton t-shirt and swab. Therefore, the HIST1 concentration should have remained 
the same for both sample types.  
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Table 18: Concentration (nmol/mL) of signature peptides in saliva and semen mixture at 












1:5 0.047 0.079 0.446 0.63 6.265 
1:2 0.071 0.172 1.21 1.938 27.228 
1:1 0.064 0.091 0.651 2.176 29.016 
2:1 ND 0.057 0.291 1.994 28.099 












1:5 0.308 0.611 6.000 4.36 45.857 
1:2 0.202 0.362 4.571 5.245 65.07 
1:1 ND 0.151 1.876 7.669 95.154 
2:1 0.092 0.096 1.648 8.225 113.58 
5:1 0.058 0.048 0.741 8.427 129.813 
ND: not detected. 
DNA Results 
For samples processed with the protein/DNA co-extraction method DNA analyses were 
conducted in parallel to the proteomic analyses. The protein fractions of the extracts were 
analyzed on the LC-MS/MS, while some DNA fractions were analyzed by quantification, 
amplification, and capillary electrophoresis. Not all of the DNA fractions were analyzed by 
PCR-STR genotyping. Having established that the resulting DNA extracts were of sufficient 
quality and compatible with PCR, the remaining samples were evaluated based on the 
quantitation results. 
The DNA fractions from the 3-hour with IAA extraction were quantified, amplified, and 
underwent capillary electrophoresis to produce STR profiles (see Figure 5). The initial 
concentration of the samples can be found in Table 18. All samples had DNA concentrations 
sufficient for amplifying the recommended target amount of 500 pg of DNA.  
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Table 18: Human DNA concentrations for semen and saliva liquid samples using 3-hour with 
IAA co-extraction method. 
Sample  
Type 




















Full profiles were observed for all saliva and semen samples, with the exception of semen 
Donor C, which had an allelic dropout at TPOX (Figure 5). There were no full locus dropouts. 
Yindel and DYS391 were part of the STR marker panel but they were excluded from Figure 5 
because they are not applicable to females. Yindel and DYS391 were present in all male donors. 
The STR profiles of all the samples show signs of degradation, with a ski slope shape.  
 
Figure 5: Heat map from DNA co-extracted from five liquid semen and five liquid saliva 
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Human DNA concentrations were established for the DNA fractions from the minimum 
sample volume analysis.  DNA was isolated from different volumes of body fluids: 2, 1, 0.5 and 
0.1 µL. The samples were extracted once but quantified twice. The semen samples had higher 
DNA concentrations than the saliva samples. The initial volume of the body fluid and the 
concentration of the extracted DNA should be directly proportional. For example, the DNA 
concentration of a sample that has an initial volume of 2 µL should be twice that of the DNA 
concentration of a sample that has an initial volume of 1 µL. Figure 6 displays the relationship 
between the initial volume of liquid saliva and DNA concentration. For saliva, there was a 
reliable correlation between the two variables (R2= .9538), see Figure 6. This correlation was not 
as reliable for the semen sample (R2=0.6948), see Figure 7. For semen, the DNA extracted from 
2 µL of semen was 6.5X more concentrated than the DNA extracted from 1 µL. Moreover, 0.5 
µL of semen resulted in a slightly higher concentration of DNA than 1 µL.  
 
Figure 6: Average DNA concentrations for saliva dilution series.  
 


























Volume of saliva: Donor 1
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Figure 7: Average DNA concentrations for semen dilution series.  
The DNA fractions of the repeatability analysis were also examined. Liquid samples 
were analyzed in triplicates for a total of n=30 samples. The relative standard deviation was 
calculated over all DNA concentrations, see Figure 8. Like with the protein fractions, the values 
over all three extractions were closer for semen than saliva. For saliva, Donor E had the lowest 
RSD, below 20%, while Donor C had the highest RSD, above 90%. For semen, Donor C had an 
RSD below 10%, whereas Donor A had an RSD above 80%. Semen donors C, D, and E as well 
as saliva Donor E had RSD values below 20%. Whereas semen donors A and B and saliva 
donors A, B, C, and D had RSD values above 60%. The DNA results for both semen and saliva 
lack consistency within the triplicates per donor. 




























Volume of semen: Donor 1
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Figure 8: A bar graph displaying the relative standard deviation in percent (%RSD) for 5 semen 
and 5 saliva donors (DNA fraction). 
 
The last set of DNA samples analyzed were extracted from the substrate and aged stain 
analysis, in which 5 µL of saliva or semen were spotted on various substrates. Table 19 provides 
a summary of the results. Again, saliva samples have lower DNA concentrations than semen 
samples, reflecting the lower amount of cellular material present (Butler, 2011). For the saliva 
samples, the stain on the polyester t-shirt produced the highest DNA concentration, followed by 
blue denim and white cotton. The semen stain on black cotton had the highest DNA 
concentration for semen, followed by polyester t-shirt and cotton swab.  Polyester swab had low 
DNA concentrations for both saliva and semen. However, the CEP swab had even lower DNA 
concentrations, for saliva. Two different donors had been the source for the 2014 cotton t-shirt 
and swab stains. DNA yields for both donors were higher than for the contemporary samples, a 
finding most likely based on biological variation of DNA carrying sperm cells counts amongst 
males. There was no systematic difference between the two donors. For the cotton t-shirt, Donor 














Repeatability of DNA Quantity
Donor A Donor B Donor C Donor D Donor E
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Table 19: Human DNA concentrations for semen and saliva stains on different stain substrates.  




Blue Denim * 2.599 9.098 
Black Cotton* 1.553 26.402 
Tissue Paper* 1.442 12.679 
White Cotton* 2.420 11.459 
Polyester T-Shirt* 4.173 18.610 
Polyester Swab# 0.027 1.172 
Cotton Swab# 0.109 13.346 
CEP Swab# 0.011 5.016 
2014 Cotton T-Shirt^ Donor 1 74.61 
Donor 2 96.05 
2014 Cotton Swab^ Donor 1 88.31 
Donor 2 85.97 
 
* two donors, one for semen, one for saliva 
# two different donors, one for semen, one for saliva 
^ third and fourth semen donor 
Discussion   
The goal of this project was to create a semi-quantitative assay for body fluid 
identification, using liquid chromatography tandem mass spectrometry. The LCMS triple 
quadrupole mass spectrometer was successfully adapted for proteomic analysis of body fluids 
using five signature peptides—three for saliva and two for semen. The saliva specific HIST1 
protein was selected for preliminary testing. However, a published study examined histatin-1 as a 
saliva biomarker and observed that it was only found in 30% of donors (Legg et al., 2017). In 
that study, five additional saliva markers were analyzed (cystatin SA, cystatin D, submaxillary 
gland androgen-regulated protein, statherin and mucin 5B) and the sample size for saliva donors 
was n=50. The submaxillary gland androgen-regulated protein (SMR3B) marker was the only 
one that was successfully detected in 100% of the saliva samples tested by Legg et al. (2017). 
The study concluded that the histatin-1 marker was not robust in terms of its detection; therefore, 
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cannot serve as a reliable saliva marker alone (Legg et al., 2017). In our study, we used the same 
marker for histatin-1 as Legg et al. (2017) and also faced difficulties due to the markers lack of 
robustness. HIST1 was proven to be problematic with a low detection sensitivity. For 
submaxillary gland androgen-regulated protein 3B, we used the markers (SMR3B-pep1 and 
SMR3B-pep2) that were utilized in the Legg et al. (2017) saliva panel, and  identified as 
confirmatory biomarkers (Legg et al., 2017). For our study, the SMR3B markers were detected 
even in low saliva volumes, 1µL for SMR3B-pep1 and <0.1µL for SMR3B-pep2. However, the 
sensitivity of the markers varies from donor to donor due to the different peptide concentrations. 
No inconsistencies were observed with both markers, e.g. as the volume of saliva decreased, the 
concentration of the peptide decreased. Additionally, SMR3B-pep1 and SMR3B-pep2 were 
successfully detected on all substrates analyzed. 
The semen markers, SEMG1-pep1 and SEMG1-pep2 both originate from the 
semenogelin-1 protein. The markers utilized in this study was part of the Legg et al. semen panel 
(2017). In that study, the SEMG1 markers were detected in 100% of the donors (n=50) (Legg et 
al., 2017). The SEMG1 markers were identified as confirmatory biomarkers for semen, along 
with semenogelin-2 markers (Legg et al., 2017). The SEMG1 peptides displayed high sensitivity 
in our method. Each peptide was detected in 0.1 µL samples, although the sensitivity was donor-
based. They were also detected on all substrates and showed low signal variability.  
Authentic samples were used to determine the minimum sample volume for the peptides. 
The minimum sample volume of the authentic peptides should be similar to the cutoffs observed 
for the synthetic peptides. This was the case for SMR3B-pep2, which was the most sensitive 
peptide for the saliva samples. For the authentic semen sample, SEMG1-pep1 and SEMG1-pep2 
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showed similar sensitivities. However, higher concentrations of SEMG1-pep2 were found in 
most donors.  
This assay can be modified by the addition of more biomarkers. The LCMS that was 
utilized for this project can target up to fifty m/z. More research can be done on alternative 
biomarkers. Additional saliva biomarkers can be analyzed such as cystatin SA and statherin, 
which were found in 94% and 90%, respectively, of the samples tested according to the Legg et 
al. study (2017). For semen, semenogelin-2 markers can also be examined. 
Prior to the instrumental analysis of these signature peptides, samples needed to be 
processed to generate defined size peptides in a particle free solution compatible with LC-
MS/MS separation and ionization. The required trypsin digestion is commonly allowed to 
incubate overnight (Legg et al., 2017; Van Steendam et al., 2013; Yang et al., 2013). Therefore, 
this method comparison included overnight trypsin digestion as one of the tested procedures. 
However, overnight procedures are time-consuming and cause problematic delays in forensic 
casework.  For a faster turn-around, the digestion was reduced to 3-hour. There was little to no 
difference in the peptide recovery for most donors, when comparing the overnight and 3-hour 
durations. For some donors, the 3-hour digestion actually improved peptide recovery. Hence, 
three-hour digestions were utilized for proceeding analyses.  
To reduce the overall time of the analysis, the alkylation step was removed, but this led to 
a loss in peptide signal and concentration. The alkylation step is very important to the recovery 
of the peptides, especially when using a highly sensitive method such as LCMS (Boja & Fales, 
2001). For thorough peptide recovery, disulfide bonds must undergo reduction and sulfhydryl 
groups should undergo alkylation (Suttapitugsakul, Xiao, Smeekens, & Wu, 2017). Without 
these steps, there will be difficulties detecting peptides that are involved in the disulfide bonds 
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(Suttapitugsakul et al., 2017). Additionally, it has been suggested that treating samples with IAA 
may help proteins overcome enzymatic degradation (Boja & Fales, 2001). However, 
overalkylation can occur at a pH near 7 (Boja & Fales, 2001).  
It is very important to purify the final peptide digests. Sample debris, such as dye or fiber, 
can hinder the peptide signal and clog the LCMS. The nano|filter and Microcon methods proved 
to be the most successful (Table 11). The nano|filters make the purification process very simple 
for liquid sample analysis. No a priori knowledge is necessary to use the vials, and there is little 
to no sample loss. However, when working with substrate samples, a press device may be needed 
to completely filter the digests and the filters are easily clogged, which makes substrate analysis 
tedious. Kranes et al. combined trypsin digestion and Microcon filtration to simultaneously 
extract DNA and peptides (2017). The Microcon method is more time-consuming than the 
nano|filter method, but the Microcon filters do not clog as easily as the nano|filters. Using the 
Microcon method, DNA can also be extracted, and further DNA analysis can be done. Hence, 
the Microcon method was used for further studies. In the original paper, the trypsin digestion and 
Microcon co-extraction method had been utilized to isolate protein and DNA components from 
fingerprints. They found that the DNA yields were similar to a proteinase K extraction (Kranes et 
al., 2017). 
The establishment of peptide separation and detection modes on an instrument previously 
used for toxicology required the purchase of a peptide separation column like the Agilent 
AdvanceBio Peptide mapping column and a peptide calibration standard like the Pierce™ 
Retention Time Calibration Mixture (Thermo Scientific™, Waltham, MA)  (results not shown). 
The next step was to determine the precursor and product ions to target for MRM mode specific 
to the selected body fluid markers. This was achieved using synthetic peptides for each target. 
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The retention times of the peptides ranged from approximately 10 to 14 minutes. Although 
HIST1 and SMR3B-pep2 showed very similar retention times, they have different transitions; 
therefore, they could be correctly identified and quantified.  
The repeatability study showed that the quantification of the semen peptides is 
repeatable, but this was not the case for saliva peptides. There was high intra-variability with the 
saliva peptide signal even though these tests were performed using the same donor. Since 
multiple aliquots were digested, a possible cause could be uneven distribution of the target 
proteins in the sample. A reproducibility study still needs to be conducted to determine the inter-
variability of each signal. The addition of a labeled peptide as internal standard may improve 
these results. 
Using the described methodology, saliva and semen peptides were detected on multiple 
substrates. The substrates examined are commonly used material and fabrics as well as swabs 
used for evidence collection. The peptides signal was not hindered, and peptides were detected 
on all substrates. The most challenging substrate was denim because it was highly absorptive, 
soaking up all the reagents. However, peptides were detected for all denim stains, with only a 
single signal dropping out. Moreover, the mixture analysis shows that the presence of one 
peptide does not hinder the signal of another. Semen and saliva peptides can be simultaneously 
detected in a mixture and a relative quantification can be made. With the saliva proteins, 
especially histatin 1 being present at lower levels and resulting in less intense signals, as 
expected saliva detection was partial for the saliva as the minor component in the 5:1 mixture. In 
order to determine if the presence of semen affects the signal of the saliva peptides and vice 
versa, an analysis needs to be conducted that uses ratios in which the volume of one of the body 
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fluids remains constant as the volume of the other changes. Then, it can be determined if the 
presence and quantity of one body fluid depresses the signal of the peptides in the other. 
Lastly, resulting DNA fractions were compatible with qPCR and STR typing with no 
indication of inhibition. The STR electropherograms had ski slope shapes, which is an indicator 
of degradation. The reason for the degradation is unknown and needs to be explored. As 
expected, the semen DNA fractions had an overall greater concentration of DNA than the saliva 
DNA fraction.  However, the correlation between the initial sample volume and the DNA 
concentration is stronger for saliva than semen. As the volume of saliva decreases, the 
concentration of the DNA decreases as well. This may be related to uneven distribution of 
cellular material with the liquid samples, but in terms of repeatability, more semen samples were 
consistent within the replicates. Moreover, DNA was sufficiently extracted from various 
substrates. DNA extracted from polyester t-shirt, blue denim, and white cotton had the highest 
DNA concentration for saliva. DNA extracted from the black cotton, polyester t-shirt, and cotton 
swabs gave the highest DNA concentration for semen. A high quantity of DNA was extracted 
from the aged semen stains. For future analysis, STR profiles should be produced for the 
substrate samples to determine if there are signs of inhibition and increased degradation.  
Overall, this test design was successful. There were no nonspecific signals for these two 
fluids. The semen peptides were only detected in semen samples and the saliva peptides were 
only detected in saliva samples. The final sample preparation method is less time consuming 
than previously published methods  (Legg et al., 2017; Van Steendam et al., 2013; Yang et al., 
2013) due to the reduced digestion times. and has the advantage of also generating a DNA 
fraction, thus reducing evidence consumption. Future work will focus on adding additional 
semen and saliva markers, as well as increasing sensitivity. With the use of a co-extraction 
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method, body fluid and DNA testing can be combined and if necessary conducted alongside 
genetically variant peptide analysis, which can produce valuable information on the identity of 
the donor (Kranes et al., 2017; Sterling et al., 2019). The method also shows promise for 
toxicology applications where signature peptide quantitation could serve as an internal marker 
for biological matrix variation and proteomic analysis can be used to identify and examine drug 
resistance-associated proteins (Cruz et al., 2017). The developed method for body fluid detection 
can be used to provide specific and sensitive results and isn’t time-consuming, unlike enzymatic, 
antibody-based and chemical techniques.   
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